Alfa Institute of Biomedical Sciences, Athens, Greece.
PLoS One. 2011 Feb 9;6(2):e16300. doi: 10.1371/journal.pone.0016300.
The impact factors of biomedical journals tend to rise over time. We sought to assess the trend in the impact factor, during the past decade, of journals published on behalf of United States (US) and European scientific societies, in four select biomedical subject categories (Biology, Cell Biology, Critical Care Medicine, and Infectious Diseases).
We identified all journals included in the above-mentioned subject categories of Thomson Reuters Journal Citation Reports® for the years 1999, 2002, 2005, and 2008. We selected those that were published on behalf of US or European scientific societies, as documented in journal websites.
We included 167 journals (35 in the subject category of Biology, 79 in Cell Biology, 27 in Critical Care Medicine, and 26 in Infectious Diseases). Between 1999 and 2008, the percentage increase in the impact factor of the European journals was higher than for the US journals (73.7±110.0% compared with 39.7±70.0%, p = 0.049). Regarding specific subject categories, the percentage change in the factor of the European journals tended to be higher than the respective US journals for Cell Biology (61.7% versus 16.3%), Critical Care Medicine (212.4% versus 65.4%), Infectious Diseases (88.3% versus 48.7%), whereas the opposite was observed for journals in Biology (41.0% versus 62.5%).
Journals published on behalf of European scientific societies, in select biomedical fields, may tend to close the "gap" in impact factor compared with those of US societies. WHAT'S ALREADY KNOWN ABOUT THIS TOPIC?: The impact factors of biomedical journals tend to rise through years. The leading positions in productivity in biomedical research are held by developed countries, including those from North America and Western Europe. WHAT DOES THIS ARTICLE ADD?: The journals from European biomedical scientific societies tended, over the past decade, to increase their impact factor more than the respective US journals.
生物医学期刊的影响因子往往随着时间的推移而上升。我们试图评估过去十年中,在美国(US)和欧洲科学学会代表出版的四个选定的生物医学学科领域(生物学、细胞生物学、危重病医学和传染病)期刊的影响因子趋势。
我们从汤森路透期刊引文报告®中确定了 1999 年、2002 年、2005 年和 2008 年上述学科领域的所有期刊。我们选择了那些在期刊网站上记录的由美国或欧洲科学学会代表出版的期刊。
我们纳入了 167 种期刊(生物学领域 35 种、细胞生物学 79 种、危重病医学 27 种、传染病 26 种)。在 1999 年至 2008 年间,欧洲期刊影响因子的增长率高于美国期刊(73.7±110.0%比 39.7±70.0%,p=0.049)。在具体学科领域,欧洲期刊的因子变化百分比往往高于相应的美国期刊,细胞生物学(61.7%比 16.3%)、危重病医学(212.4%比 65.4%)、传染病(88.3%比 48.7%),而生物学期刊则相反(41.0%比 62.5%)。
在选定的生物医学领域,代表欧洲科学学会出版的期刊可能倾向于缩小与美国学会的影响因子差距。
生物医学期刊的影响因子往往随着时间的推移而上升。在生物医学研究方面,生产力的领先地位由发达国家占据,包括北美和西欧国家。
在过去十年中,欧洲生物医学科学学会的期刊倾向于比相应的美国期刊增加更多的影响因子。